Patent Assignment
Reel/Frame 073116/0803
Assignment of Assignor's Interest
Recorded: 2025-10-20
Pages: 13
Assignor
BEIGENE, LTD.
Executed: 2025-09-30
Assignee
BEONE MEDICINES I GMBH
AESCHENGRABEN 27, BASEL, 4051, SWITZERLAND
Covered Properties
(73)
Fused Tricyclic Compounds as Raf Kinase Inhibitors
Fused Tricyclic Compounds as Raf Kinase Inhibitors
Fused Tricyclic Compounds as Raf Kinase Inhibitors
Maleate Salts of a B-Raf Kinase Inhibitor, Crystalline Forms, Methods of Preparation, and Uses Therefore
SUBSTITUTED CYCLOOCTA[5,6]PYRIDO[4,3,2-de]PHTHALAZINES AS PARP INHIBITORS
Substituted 5-(3,5-Dimethylisoxazol-4-Yl)Indoline-2-Ones
Substituted 5-(3,5-Dimethylisoxazol-4-Yl)Indoline-2-Ones
Fused Tricyclic Urea Compounds as Raf Kinase and/or Raf Kinase Dimer Inhibitors
Fused Tricyclic Urea Compounds as Raf Kinase and/or Raf Kinase Dimer Inhibitors
Fused Tricyclic Urea Compounds as Raf Kinase and/or Raf Kinase Dimer Inhibitors
Fused Tricyclic Urea Compounds as Raf Kinase and/or Raf Kinase Dimer Inhibitors
NOVEL 5 OR 8-SUBSTITUTED IMIDAZO[1, 5-a] PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES
Novel 5 or 8-Substituted Imidazo[1,5-a]Pyridines as Indoleamine and/or Tryptophane 2,3-Dioxygenases
5 OR 8-SUBSTITUTED IMIDAZO [1,5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2,3-DIOXYGENASES
CRYSTALLINE FORMS OF (S)-7-(1-(BUT-2-YNOYL)PIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE, PREPARATION, AND USES THEREOF
Pyrazolotriazolopyrimidine Derivatives as A2A Receptor Antagonist
IMIDAZO[1,5-a]PYRAZINE DERIVATIVES AS PI3K DELTA INHIBITORS
IMIDAZO[1,5-a]PYRAZINE DERIVATIVES AS PI3K DELTA INHIBITORS
Imidazo[1,5-A]Pyrazine Derivatives as PI3KDELTA Inhibitors
Btk Inhibitors with Improved Dual Selectivity
Novel Benzoimidazoles as Selective Inhibitors of Indoleamine 2,3-Dioxygenases
Imidazo[2,1-F][1,2,4]Triazin-4-Amine Derivatives as TLR7 Agonist
Immunotherapy for Hepatocellular Carcinoma
Anti-Pd-L1 Antibodies and Their Use as Therapeutics and Diagnostics
Anti-Pd-L1 Antibodies and Their Use as Therapeutics and Diagnostics
Anti-OX40 Antibodies and Methods of Use
Imidazo[1,5-A]Pyrazine Derivatives as PI3KDELTA Inhibitors
Bcl-2 Inhibitor
3-[(1H-Pyrazol-R-Yl)Oxy]Pyrazin-2-Amine Compounds as HPK1 Inhibitor and Use Thereof
Cyclic Dinucleotides as Sting Agonists
Imidazo[2,1-F][1,2,4]Triazin-4-Amine Derivatives Used as TLR8 Agonists
Pyrazolotriazolopyrimidine Derivatives as A2A Receptor Antagonist
Application:
17/261,359 →
Publication:
US 2021/0300936
Stable Solid Dispersion of a B-Raf Kinase Dimer Inhibitor, Methods of Preparation, and Uses Therefor
Bcl-2 INHIBITORS
Inhibitors of Kras G12C
Application:
17/763,720 →
Publication:
US 2022/0389021
Imidazo[2,1-F][1,2,4]Triazin-4-Amine Derivatives as TLR7 Agonist
Amide-Substituted Imidazo Compounds as Selective Inhibitors of Indoleamine 2,3-Dioxygenases
Application:
17/612,056 →
Publication:
US 2022/0227762
Degradation of Bruton's Tyrosine Kinase (Btk) by Conjugation of Btk Inhibitors with E3 Ligase Ligand and Methods of Use
Application:
17/629,910 →
Publication:
US 2022/0281876
Aminopyrazine Compounds as HPK1 Inhibitor and the Use Thereof
Application:
17/636,473 →
Publication:
US 2022/0289712
Substituted Pyrazoles as Sting Modulators
Application:
17/767,115 →
Publication:
US 2022/0289768
Tyk-2 Inhibitor
Degradation of Bruton's Tyrosine Kinase (Btk) by Conjugation of Btk Inhibitors with E3 Ligase Ligand and Methods of Use
Application:
17/910,037 →
Publication:
US 2023/0322761
(R) AND (S)-3-(TERT-BUTYL)-N-(1-(4-(6-(6-(4-((1-(4-(2,4-DIOXOTETRAHYDROPYRIMIDIN-1(2H)-YL)PHENYL)PIPERIDIN-4-YL)METHYL)PIPERAZIN-1-YL)PYRIDIN-3-YL)-7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-2-METHYLPHENYL)ETHYL)-1,2,4-OXADIAZOLE-5-CARBOXAMIDE AS BRUTON'S TYROSINE KINASE (BTK) DEGRADERS
Application:
17/919,847 →
Publication:
US 2023/0167118
Heterocyclic Compounds as Sting Modulators
Application:
17/925,854 →
Publication:
US 2023/0212192
Pyrido[2,3-B][1,4]Oxazines or Tetrahydropyrido[2,3-B][1,4]Oxazepines as Iap Antagonists
Interleukin 15 Constructs and Methods of Use
Application:
18/245,654 →
Publication:
US 2023/0357344
Imidazotriazine and Pyrrolopyrimidine Derivatives as Kras G12C Inhibitors
Application:
18/040,667 →
Publication:
US 2023/0322788
Tyk-2 Inhibitor
Application:
18/011,590 →
Publication:
US 2024/0043435
Indoline Compounds and Derivatives as Egfr Inhibitors
Application:
18/027,665 →
Publication:
US 2023/0373960
Degradation of (Egfr) by Conjugation of Egfr Inhibitors with E3 Ligase Ligand and Methods of Use
Application:
18/015,561 →
Publication:
US 2023/0248834
Bifunctional Compounds for Degradation of Egfr and Related Methods of Use
Application:
18/029,227 →
Publication:
US 2024/0025902
Degradation of (Egfr) by Conjugation of Egfr Inhibitors with E3 Ligase Ligand and Methods of Use
Application:
18/016,292 →
Publication:
US 2023/0265116
Heterocyclic Compounds, Compositions Thereof, and Methods of Treatment Therewith
Application:
18/597,844 →
Publication:
US 2024/0262848
Substituted 6-(Pyrimidin-4-yl)Quinoline Compounds as Cyclin Dependent Kinase Inhibitors
Application:
18/623,847 →
Publication:
US 2024/0300937
Degradation of (Egfr) by Conjugation of Egfr Inhibitors with E3 Ligase Ligand and Methods of Use
Application:
18/771,529 →
Publication:
US 2024/0368203
4-(Aminomethyl)-6-(1-Methyl-1H-Pyrazol-4-YL)Isoquinolin-1(2H)-One Derivatives as MTA-Cooperative Inhibitors of PRMT5
Application:
18/825,776 →
Publication:
US 2025/0000854
Heterocyclic Compounds, Compositions Thereof, and Methods of Treatment Therewith
Application:
18/889,657 →
Publication:
US 2025/0101028
Thiazolopyridyl Amide Derivatives as DNA Polymerase Theta Inhibitors
Application:
18/761,919 →
Publication:
US 2025/0026766
Bcl-Xl Inhibitors
Application:
18/894,069 →
Publication:
US 2025/0034128
Heterocyclic Compounds, Compositions Thereof, and Methods of Treatment Therewith
Application:
18/796,700 →
Publication:
US 2025/0163047
Bcl-2 Inhibitors
Application:
18/745,423 →
Publication:
US 2024/0376104
Small Molecule IL-17A Modulators
Application:
18/918,712 →
Publication:
US 2025/0154138
Heterocyclic Compounds, Compositions Thereof, and Methods of Treatment Therewith
Application:
18/934,390 →
Publication:
US 2025/0066372
Substituted 7-(Pyrimidin-4-yl)Quinolin-4(1H)-One Compounds as Cyclin Dependent Kinase Inhibitors
Application:
18/926,544 →
Publication:
US 2025/0136586
Degradation of IRAK4 by Conjugation of IRAK4 Inhibitors with E3 Ligase Ligand and Methods of Use
Application:
18/972,490 →
Publication:
US 2025/0195513
Antibody Drug Conjugates
Application:
18/971,958 →
Publication:
US 2025/0099607
Anti-CCR8 Antibodies and Methods of Use
Application:
18/930,933 →
Publication:
US 2025/0115671
Anti-cMET Antibodies and Methods of Use
Application:
18/957,490 →
Publication:
US 2025/0154265
Anti-GPC3 and Anti-CD137 Multispecific Antibodies and Methods of Use
Application:
18/954,427 →
Publication:
US 2025/0154279
Anti-FGFR2b Antibodies, Conjugates and Methods of Use
Application:
19/008,844 →
Publication:
US 2025/0222125
Heterocyclic Compounds, Compositions Thereof, and Methods of Treatment Therewith
Application:
19/011,372 →
Publication:
US 2025/0221996
BCL-2 Inhibitor
Application:
19/035,219 →
Publication:
US 2025/0270210
3-[(1H-Pyrazol-4-Yl)Oxy]Pyrazin-2-Amine Compounds as HPK1 Inhibitor and Use Thereof
Application:
19/176,735 →
Publication:
US 2025/0236610
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 23, 2014
From: ZHOU, CHANGYOU; ZHANG, GUOLIANG; WANG, SHAOHUI
To: BEIGENE LTD.
Reel/Frame 034022/0461 →
Assignment of Assignor's Interest
Mar 5, 2015
From: ZHOU, CHANGYOU; REN, BO; WANG, HEXIANG
To: BEIGENE LTD.
Reel/Frame 035097/0705 →
Assignment of Assignor's Interest
Aug 20, 2015
From: REN, BO; ZHOU, CHANGYOU; WANG, HEXIANG
To: BEIGENE, LTD.
Reel/Frame 036381/0842 →
Assignment of Assignor's Interest
Jan 25, 2016
From: ZHOU, CHANGYOU; WANG, SHAOHUI; ZHANG, GUOLIANG
To: BEIGENE, LTD.
Reel/Frame 037572/0528 →
Assignment of Assignor's Interest
Jan 26, 2016
From: ZHOU, CHANGYOU; ZHANG, GUOLIANG
To: BEIGENE, LTD.
Reel/Frame 037592/0195 →
Assignment of Assignor's Interest
Sep 29, 2016
From: REN, BO; WANG, HEXIANG; ZHOU, CHANGYOU
To: BEIGENE LTD.
Reel/Frame 039892/0629 →
Assignment of Assignor's Interest
Jun 26, 2017
From: ZHOU, CHANGYOU; ZHANG, GUOLIANG
To: BEIGENE, LTD.
Reel/Frame 042815/0140 →
Assignment of Assignor's Interest
Oct 12, 2017
From: WANG, HEXIANG; ZHANG, GUOLIANG; GUO, YUNHANG; REN, BO
To: BEIGENE, LTD.
Reel/Frame 043844/0199 →
Assignment of Assignor's Interest
Oct 12, 2017
From: ZHANG, GUOLIANG; ZHOU, CHANGYOU
To: BEIGENE, LTD.
Reel/Frame 043845/0814 →
Assignment of Assignor's Interest
Jan 31, 2018
From: ZHOU, CHANGYOU; WANG, SHAOHUI; ZHANG, GUOLIANG
To: BEIGENE, LTD.
Reel/Frame 044781/0664 →
Assignment of Assignor's Interest
Jan 31, 2018
From: ZHOU, CHANGYOU; ZHANG, GUOLIANG
To: BEIGENE, LTD.
Reel/Frame 044781/0683 →
Assignment of Assignor's Interest
Mar 13, 2019
From: ZHOU, CHANGYOU; ZHANG, GUOLIANG
To: BEIGENE, LTD.
Reel/Frame 048580/0706 →
Assignment of Assignor's Interest
Mar 28, 2019
From: WANG, HEXIANG; ZHANG, GUOLIANG; GUO, YUNHANG; REN, BO
To: BEIGENE, LTD.
Reel/Frame 048724/0399 →
Assignment of Assignor's Interest
Jul 23, 2019
From: GUO, YUNHANG; YU, DESHENG; WANG, ZHIWEI
To: BEIGENE, LTD.
Reel/Frame 049830/0832 →
Assignment of Assignor's Interest
Jul 25, 2019
From: WANG, HEXIANG; ZHANG, GUOLIANG; GUO, YUNHANG; REN, BO
To: BEIGENE, LTD.
Reel/Frame 049861/0939 →
Assignment of Assignor's Interest
Oct 21, 2019
From: LI, JING; ZHAO, HAIBO; WANG, ZHIWEI
To: BEIGENE, LTD.
Reel/Frame 050776/0035 →
Assignment of Assignor's Interest
Sep 21, 2020
From: ZHANG, GUOLIANG; ZHOU, CHANGYOU
To: BEIGENE, LTD.
Reel/Frame 053829/0622 →
Assignment of Assignor's Interest
Nov 19, 2020
From: REN, BO; ZHOU, CHANGYOU; WANG, HEXIANG
To: BEIGENE, LTD.
Reel/Frame 054421/0079 →